Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Acta Anaesthesiol Scand ; 59(2): 205-14, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25476578

RESUMO

BACKGROUND: Surgical checklists (SCs) have been developed to enhance teamwork and facilitate handovers, thereby improving the safety of surgical patients in health care organisations. The aim of this study was to determine whether the implementation of a 39-item SC reduced mortality and surgical adverse events (AEs) in patients undergoing inpatient surgery. METHODS: A retrospective pre- and post-intervention study of two cohorts of surgical patients was conducted (n = 1602) in a tertiary teaching hospital. The patients' homogeneity was confirmed by studying 40 comorbidities, 13 analytical determinations and 14 patient- and intervention-related variables. A 39-item SC adapted from one by the World Health Organization was used. The primary endpoint was the occurrence of any AE, including death, within 30 days of the operation. Twenty-three types of AEs were analysed. RESULTS: Following implementation of the checklist, the rate of AEs per 100 patients decreased from 31.5% to 26.5% (P = 0.39), the rate of infectious AEs decreased from 13.9 to 9.6 (P = 0.037) and non-infectious AEs decreased from 17.5 to 16.8 (P = 0.82). For non-elective patients, total AEs decreased from 60.4 to 37.0 (P = 0.017). The proportion of patients with one or more AE decreased from 18.1% to 16.2% (P = 0.35), and the death rate at 30 days decreased from 1.5% to 0.9% (P = 0.35). CONCLUSION: The overall AE rate did not decrease significantly between the two periods. However, the rate of infectious AEs and overall AEs in patients with non-elective admissions had statistically significant reductions. Further research is needed to determine how and in which patients SC introduction can work successfully.


Assuntos
Lista de Checagem/métodos , Mortalidade Hospitalar , Complicações Pós-Operatórias/mortalidade , Complicações Pós-Operatórias/prevenção & controle , Feminino , Hospitais de Ensino , Humanos , Tempo de Internação/estatística & dados numéricos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos
2.
Rev Neurol ; 25 Suppl 3: S214-21, 1997 Sep.
Artigo em Espanhol | MEDLINE | ID: mdl-9273165

RESUMO

Neurocutaneous syndromes constitute a large and complex group of diseases in which recent medical advances, particularly in the field of molecular biology and genetics, have afforded a deeper understanding of the way in which these diseases originate. In this article, we review the advances concerning pathogenic mechanisms. First, we discuss the malformations disorders of the central nervous system associated with skin disorders, which range from spinal and/or cranial dysraphism with skin lesions to fustrated forms of malformations of the neural tube, such us membranous aplasia cutis. Neurocutaneous vascular disorders can be due to malformational disease, such as in Sturge-Weber syndrome, as well as to autoimmune diseases. The analysis of mutations affecting the capacity for migration and differentiation of melanocyte precursors enables us to gain a better understanding of disorders of the cells of the neural crest, such as piebaldism and Waardenburg's syndrome. Mutations in tumor suppressor genes play an important part in the development of hamartomatous and neoplastic lesions in neurofibromatosis and tuberous sclerosis. Genetic mosaicism, both of the functional and the genomic kind, accounts for the great diversity of phenotypes and the distribution of neurocutaneous diseases. Lastly, neurocutaneous syndromes such as the paracrinopathies form an attractive hypothesis, which is as yet to be confirmed.


Assuntos
Mosaicismo/genética , Defeitos do Tubo Neural/etiologia , Neurofibromatose 1/etiologia , Disrafismo Espinal/etiologia , Síndrome de Waardenburg/etiologia , Síndrome de Waardenburg/genética , Movimento Celular , Genes Supressores de Tumor , Genes ras , Humanos , Melanócitos/fisiologia , Crista Neural/embriologia , Defeitos do Tubo Neural/embriologia , Neurofibromatose 1/genética , Mutação Puntual , Disrafismo Espinal/embriologia , Disrafismo Espinal/genética , Fator de Células-Tronco
3.
Rev Neurol ; 25(144): 1168-70, 1997 Aug.
Artigo em Espanhol | MEDLINE | ID: mdl-9340138

RESUMO

INTRODUCTION AND OBJECTIVE: SPECT with 201Tl provides information regarding the degree of malignancy of cerebral tumours, their possible relapses, the differentiation of necrotic tissue in the tumours following chemotherapy or radiotherapy and permits differentiation into zones of various grades of histological malignancy. MATERIAL AND METHODS: We carried out a prospective analysis of the usefulness of SPECT with 201Tl for the histological prognosis of cerebral tumours. For one year 68 patients diagnosed (on CT and/or MR) as having an expansive cerebral lesion were studied. The early uptake (ICP) and retention (R) indices were calculated, and these results correlated with the morbid anatomy (AP) findings and the results obtained with surgery and stereotactic biopsy. Four patients were excluded due to lack of AP results. RESULTS: Significant differences were found between the ICP of grade I-II astrocytomas (1.34 +/- 0.52) and glioblastomas multiformes (2.56 +/- 0.57), between the ICP of meningiomas (4.53 +/- 1.68) and metastases (2.45 +/- 0.58) and between those of meningiomas and all glial tumours. With regard to IR, we saw significant differences between the figures for meningiomas (0.63 +/- 0.13) and meningiomas with malignant relapses (0.94 +/- 0.17) and between metastases (0.8 +/- 0.03) and all glial tumours. CONCLUSIONS: From our study, it may be concluded that rapid, high captation of 201Tl (high ICP) with a slow fall (high IR), is associated with a process showing malignancy on histological study (malignant relapse of meningioma, glioblastoma multiforme, metastasis), whilst high take-up (high ICP) with rapid elimination (low IR) corresponds to a benign hypervascularized tumour (meningioma).


Assuntos
Astrocitoma/diagnóstico por imagem , Glioblastoma/diagnóstico por imagem , Glioma/diagnóstico por imagem , Meningioma/diagnóstico por imagem , Radioisótopos de Tálio , Adulto , Idoso , Astrocitoma/patologia , Feminino , Glioblastoma/patologia , Glioma/patologia , Humanos , Masculino , Meningioma/patologia , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Valor Preditivo dos Testes , Estudos Prospectivos , Tomografia Computadorizada de Emissão de Fóton Único
4.
Rev Neurol ; 32(9): 829-32, 2001.
Artigo em Espanhol | MEDLINE | ID: mdl-11424033

RESUMO

INTRODUCTION: Antiaggregant and anticoagulant therapy has possible sever secondary effects, being the most serious intracranial bleeding. OBJECTIVES: Compare morbi-mortality between surgical and medical treatments in anticoagulated and/or antiaggregated patients with any kind of intracranial bleeding. Also risk factors and main indications of those treatments are studied. PATIENTS AND METHODS: Descriptive and retrospective study including 105 patients admitted in our Critical Care Unit, with intracranial bleeding, under anticoagulant or antiaggregant treatment. We study the type of bleeding (subarachnoid, epidural, subdural and intraparenchimal bleeding) and the relation between morbi-mortality and treatment applicated using relative risk like analytic tool. RESULTS: Major bleeding risk appears after the six first months from the beginning of the treatment. Thirty-four patients died with a relative risk of 1.55 in the surgical patients from the medical treatment patients. Relative risk between anticoagulated patients and antiaggregated ones was 1.16. Serious consequences happened on eight of the 49 patients under surgical treatment, and on 13 of the 52 patients under medical treatment. CONCLUSIONS: Surgical treatment has more morbi-mortality. Oral anticoagulation has only a little more relative risk than treatment with antiaggregants. Both groups had serious consequences.


Assuntos
Anticoagulantes/administração & dosagem , Anticoagulantes/efeitos adversos , Encéfalo/cirurgia , Hemorragias Intracranianas , Inibidores da Agregação Plaquetária/administração & dosagem , Inibidores da Agregação Plaquetária/efeitos adversos , Vitamina K/uso terapêutico , Adulto , Idoso , Idoso de 80 Anos ou mais , Terapia Combinada , Feminino , Hemostasia/efeitos dos fármacos , Humanos , Hiperlipidemias/epidemiologia , Hemorragias Intracranianas/induzido quimicamente , Hemorragias Intracranianas/mortalidade , Hemorragias Intracranianas/terapia , Masculino , Pessoa de Meia-Idade , Prevalência , Estudos Retrospectivos , Fatores de Risco , Fumar/epidemiologia
8.
Actas Dermosifiliogr ; 99(5): 407-10, 2008 Jun.
Artigo em Espanhol | MEDLINE | ID: mdl-18501174

RESUMO

Lidocaine is one of the most widely used local anesthetics. It can be administered topically or parenterally. Allergic contact dermatitis from lidocaine is uncommon, but an increasing number of cases have been reported in recent years. We present the case of a 66-year-old man who presented with acute dermatitis on the pinna and left cheek after applying ear drops. Patch tests were positive for the product itself and for lidocaine in the ear drops, thereby confirming the diagnosis of contact dermatitis from lidocaine.


Assuntos
Anestésicos Locais/efeitos adversos , Dermatite Alérgica de Contato/etiologia , Toxidermias/etiologia , Lidocaína/efeitos adversos , Doença Aguda , Idoso , Orelha , Face , Humanos , Masculino
9.
Dermatol Surg ; 24(10): 1087-91, 1998 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-9793519

RESUMO

BACKGROUND: Vascular anomalies (hemangiomas and vascular malformations) are frequently located in the oral cavity. They can be treated by cool steel surgery, cryotherapy, laser therapy, embolization, and sclerosis. The choice of treatment should depend on the type of vascular anomaly, its site, the general condition of the patient, and the doctor's experience. OBJECTIVE: The objective of this article is to assess the usefulness, indications, and advantages of transfixion technique in the treatment of oral vascular lesions. METHODS: We present seven patients with various vascular anomalies in the oral cavity that were treated using transfixion technique. This procedure is performed with local infiltration anesthesia and it consists of interlacing a polyglycolic acid suture a number of times in an upward direction until the vascular anomaly becomes bloodless. RESULTS: In all seven patients we completely eliminated the vascular lesion without significant long-term complications. We detected a transitory retractil scar in only one patient and edema in the postoperative period in another one. CONCLUSIONS: Treatment of vascular anomalies of the oral cavity by transfixion technique is an effective, simple method that does not cause major complications and is low in cost.


Assuntos
Malformações Arteriovenosas/cirurgia , Hemangioma/cirurgia , Neoplasias Bucais/cirurgia , Boca/irrigação sanguínea , Procedimentos Cirúrgicos Bucais/métodos , Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Técnicas de Sutura
11.
J Biomed Inform ; 37(1): 30-42, 2004 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15016384

RESUMO

In this paper, we review the results of BIOINFOMED, a study funded by the European Commission (EC) with the purpose to analyse the different issues and challenges in the area where Medical Informatics and Bioinformatics meet. Traditionally, Medical Informatics has been focused on the intersection between computer science and clinical medicine, whereas Bioinformatics have been predominantly centered on the intersection between computer science and biological research. Although researchers from both areas have occasionally collaborated, their training, objectives and interests have been quite different. The results of the Human Genome and related projects have attracted the interest of many professionals, and introduced new challenges that will transform biomedical research and health care. A characteristic of the 'post genomic' era will be to correlate essential genotypic information with expressed phenotypic information. In this context, Biomedical Informatics (BMI) has emerged to describe the technology that brings both disciplines (BI and MI) together to support genomic medicine. In recognition of the dynamic nature of BMI, institutions such as the EC have launched several initiatives in support of a research agenda, including the BIOINFOMED study.


Assuntos
Biologia Computacional/métodos , Atenção à Saúde/métodos , Testes Genéticos/métodos , Terapia Genética/métodos , Genômica/métodos , Informática Médica/métodos , Projetos de Pesquisa , Biotecnologia/métodos , Biotecnologia/tendências , Biologia Computacional/tendências , Atenção à Saúde/tendências , União Europeia , Previsões , Perfilação da Expressão Gênica/métodos , Perfilação da Expressão Gênica/tendências , Testes Genéticos/tendências , Terapia Genética/tendências , Genômica/instrumentação , Programas Governamentais , Informática Médica/tendências , Pesquisa/tendências , Avaliação da Tecnologia Biomédica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA